Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or ...

Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...

A biomarker panel can improve prediction of chronic kidney disease (CKD) progression in children, according to a study ...

Kidney failure, a silent killer, often goes unnoticed as the body adapts, masking symptoms like fatigue and swelling. The kidneys don’t cry for help.

The data recorded in the Integrated Health System revealed that just over half of the patients were on nephroprotective medication and that 98 (41.2%) had increased UAE and/or a decreased GFR ...

The good news is that it’s simple to find out about your kidney health through two tests that your primary care provider can order. The first is a blood test called a metabolic panel, which can report ...

The progression of chronic kidney disease is categorized in five stages, each of which is defined by estimated glomerular filtration rate (eGFR), a measure of how well the kidneys filter blood ...

The Glomerular Filtration Rate (GFR) is a key indicator of kidney function, helping healthcare professionals assess kidney health and detect issues like chronic kidney disease (CKD) and acute ...

For Vera Therapeutics, the 200-day moving average sits at $37.56, according to Benzinga Pro, which is above the current price of $19.45. For more on charts and trend lines, see a description here.

Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave off the disease’s worst effects.

More information: Xin Yuan et al, Propagation of pathologic α-synuclein from kidney to brain may contribute to Parkinson's disease, Nature Neuroscience (2025). DOI: 10.1038/s41593-024-01866-2.